GenoFocus Inc (187420) — Cash Flow-to-Debt Ratio
GenoFocus Inc (187420) has a Cash Flow-to-Debt Ratio of -0.01x as of March 2026, meaning its operating cash flow of ₩-821.53 Million could theoretically repay 0% of its total liabilities (₩82.66 Billion) in one year. See GenoFocus Inc (187420) flexibility index to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
GenoFocus Inc Cash Flow-to-Debt Ratio (2014–2025)
Historical debt coverage capacity for GenoFocus Inc across 12 annual periods. For the full cash flow conversion analysis, see how efficiently does GenoFocus Inc generate cash.
Annual Cash Flow-to-Debt Ratio for GenoFocus Inc (2014–2025)
Year-by-year debt coverage analysis for GenoFocus Inc. Check GenoFocus Inc earnings quality ratio to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (KRW) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.04x | ₩3.50 Billion | ₩81.08 Billion | ▲ +84.4% |
| 2024 | 0.02x | ₩2.87 Billion | ₩122.49 Billion | ▲ +134.8% |
| 2023 | -0.07x | ₩-4.82 Billion | ₩71.50 Billion | ▼ -57.3% |
| 2022 | -0.04x | ₩-4.71 Billion | ₩110.02 Billion | ▼ -49.1% |
| 2021 | -0.03x | ₩-2.39 Billion | ₩83.24 Billion | ▲ +14.0% |
| 2020 | -0.03x | ₩-2.45 Billion | ₩73.46 Billion | ▼ -659.0% |
| 2019 | 0.00x | ₩-167.50 Million | ₩38.08 Billion | ▼ -102.8% |
| 2018 | 0.15x | ₩1.56 Billion | ₩10.12 Billion | ▼ -32.8% |
| 2017 | 0.23x | ₩1.36 Billion | ₩5.93 Billion | ▼ -68.4% |
| 2016 | 0.73x | ₩516.09 Million | ₩709.87 Million | ▼ -81.2% |
| 2015 | 3.88x | ₩2.85 Billion | ₩736.18 Million | ▲ +9952.7% |
| 2014 | -0.04x | ₩-286.45 Million | ₩7.28 Billion | — |